DK Life Science Co., Ltd. (KOSDAQ:303810)

South Korea · Delayed Price · Currency is KRW

2,650.00

-100.00 (-3.64%)

Oct 8, 2026, 3:30 PM KST

DK Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	84,758	117,062	-	-	-	-
Market Cap Growth	-35.44%	-	-	-	-	-
Enterprise Value	114,229	147,385	-	-	-	-
Last Close Price	2650.00	3660.00	-	-	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.02	13.52	-	-	-	-
PS Ratio	0.72	0.90	-	-	-	-
PB Ratio	0.64	0.89	-	-	-	-
P/TBV Ratio	0.66	0.93	-	-	-	-
P/OCF Ratio	10.12	269.95	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.97	1.13	-	-	-	-
EV/EBITDA Ratio	6.81	7.58	-	-	-	-
EV/EBIT Ratio	11.21	11.30	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.28	0.30	0.43	0.49	0.46	0.28
Debt / EBITDA Ratio	2.25	2.00	2.56	4.03	4.81	2.55
Debt / FCF Ratio	31.12	-	7.01	-	-	-
Net Debt / Equity Ratio	0.22	0.24	0.39	0.45	0.41	0.18
Net Debt / EBITDA Ratio	1.76	1.63	2.30	3.71	4.29	1.65
Net Debt / FCF Ratio	24.27	-6.04	6.30	-4.66	-1.84	-0.61
Asset Turnover	0.56	0.64	0.71	0.70	0.69	0.76
Inventory Turnover	2.85	2.51	2.52	2.75	3.45	4.90
Quick Ratio	1.33	1.23	1.11	0.98	1.09	1.03
Current Ratio	1.73	1.72	1.84	1.62	1.72	1.46
Return on Equity (ROE)	3.82%	7.32%	2.22%	4.46%	4.90%	7.45%
Return on Assets (ROA)	3.01%	3.98%	4.02%	3.10%	2.49%	3.16%
Return on Invested Capital (ROIC)	4.93%	6.75%	3.93%	5.49%	4.44%	7.94%
Return on Capital Employed (ROCE)	7.40%	9.50%	9.30%	7.40%	5.40%	7.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.87%	7.40%	-	-	-	-
FCF Yield	1.43%	-4.49%	-	-	-	-
Buyback Yield / Dilution	-0.52%	-12.34%	-150.51%	-900.58%	-0.01%	2.05%